Frontlight ResearchEarly access
Trial site
Hospital Maisonneuve-Rosemont
- 8running trials
- 1closed trial
The trials here
What the 9 trials at this site are about, from their registry records.
- Conditions
- Endometrial cancer1 trial
- Follicular lymphoma1 trial
- Metastatic breast cancer1 trial
- Multiple myeloma1 trial
- Obesity1 trial
- Ovarian cancer1 trial
- Psoriasis1 trial
- Psoriatic arthritis1 trial
- Type 2 diabetes1 trial
- Phase
- Phase 36 trials
- Phase 11 trial
- Phase 21 trial
- Status
- Active, not recruiting4 trials
- Recruiting3 trials
- Completed1 trial
- Not yet recruiting1 trial
- Lead sponsor
- Incyte Corporation2 trials
- Canadian Myeloma Research Group1 trial
- Janssen Research & Development, LLC1 trial
- Karyopharm Therapeutics Inc1 trial
- LeonaBio1 trial
- and 3 more
Running trials
Not yet recruiting
Study of Belantamab Mafodotin, Cevostamab, Pomalidomide for RRMM Patients (MAPLE)
Recruiting
Active, not recruiting
Recruiting
CATALINA-2: A Clinical Study of TORL-1-23 in Platinum-resistant Ovarian Cancer.
Recruiting
Active, not recruiting
Active, not recruiting
Recruiting
Randomized, Embedded, Multifactorial Adaptive Platform Trial for Community- Acquired Pneumonia
Recruiting at the same time
How many trials recruit for the same indication here at once. A count, not a rating.
- Metastatic breast cancer1 recruiting
- Multiple myeloma1 recruiting
- Ovarian cancer1 recruiting
Closed trials
Site data: ClinicalTrials.govUpdated 17 Nov 2026